ロード中...
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (Rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor receptor (EGFR). The activity against RET and...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Libertas Academica
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3153121/ https://ncbi.nlm.nih.gov/pubmed/21836817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S6197 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|